New Approved Cancer Drugs Failing Miserably

By Dr. Mercola According to the National Cancer Institute, in 2012 there were 14 million new cases of cancer diagnosed and 8.2 million cancer deaths worldwide.1 They anticipate the number of newly diagnosed cases will rise to over 20 million each year within the next two decades. These statistical trends are used to measure success of efforts to prevent or treat cancers. Mainstream medicine relies on pharmaceutical companies to develop toxins that may kill cancer cells and extend the life of those suffering from the disease. Unfortunately, cancer cells develop in unique and highly variable processes, creating cell overgrowths that do not respond to just one or two types of medication. Pressured by patient advocates who want earlier access to novel medications, the U.S. Food and Drug Administration (FDA) began approving cancer drugs without requisite proof they either extend the life of the patient or kill cancer cells.2 Meanwhile, emerging evidence indicates diets high in healthy fats
http://articles.mercola.com/sites/articles/archive/2017/03/01/cancer-drugs-failing-miserably.aspx